YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination
J Natl Compr Canc Netw. 2026 Mar 31;24(3.5):YIA26-003.
doi: 10.6004/jnccn.2025.7450.